A high omega-3, low omega-6 diet with fish oil led to a significant reduction in a biomarker for prostate cancer progression ...
Progression-free survival (PFS) in oligometastatic prostate cancer improved significantly with metastasis-directed therapy ...
For patients with metastatic castration-resistant prostate cancer (mCRPC) unselected for homologous recombination repair (HRR ...
Patients with high-risk prostate cancer had a significantly lower incidence of distant metastasis when treated with a ...
Accurate calculation of prostate-specific antigen doubling time can be crucial for prostate cancer treatment decisions but is ...
Prostate cancer kills twice as many Black men as white men in the U.S. Beyoncé's father has signed onto a new $20 million ...
An Early Blood Test Can Predict Survival in Patients With Metastatic Prostate Cancer Oct. 7, 2024 — A blood test, performed when metastatic prostate cancer is first diagnosed, can predict which ...
DelveInsight’s, “Metastatic Prostate Cancer Pipeline Insight” report provides comprehensive insights about 80+ companies and 85+ pipeline drugs in metastatic prostate cancer pipeline landscape. It ...
Prostate cancer runs in Dean's family, and screening for it every year made it relatively straightforward to address. Now, he ...
Darolutamide may offer greater benefits than enzalutamide or apalutamide for Black and White patients with non-metastatic ...
Opens in a new tab or window SAN FRANCISCO -- Progression-free survival (PFS) in oligometastatic prostate cancer improved significantly with metastasis-directed therapy (MDT) in addition to ...
For patients with metastatic castration-resistant prostate cancer (mCRPC) unselected for homologous recombination repair (HRR ...